Von Hippel–Lindau Syndrome

  • Jie ZhouEmail author
  • Xiaoran Li


Von Hippel–Lindau syndrome (VHL) is a heritable neoplastic disease resulting in multisystem carcinoma, benign tumors, and cysts. VHL is inherited in an autosomal dominant manner and could result in benign or malignant tumors, with high penetrance affecting multiple organ systems, including the central nervous system (CNS) and visceral organs [1]. Incidences of VHL are associated with a germline mutation of a tumor suppressor gene, VHL, on the short arm of chromosome 3 (3p25.5) [2].


Von Hippel–Lindau syndrome Hemangioblastoma Clear-cell renal cell carcinoma Pheochromocytoma Pancreatic neuroendocrine tumor and cystadenoma Endolymphatic sac tumor Epididymal papillary cystadenomas 


  1. 1.
    Kaelin WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2002;2(9):673–82.CrossRefGoogle Scholar
  2. 2.
    Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel–Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317–20.CrossRefGoogle Scholar
  3. 3.
    Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. J Neurosurg. 2003;98(1):82–94.CrossRefGoogle Scholar
  4. 4.
    Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel–Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117(3):371–8.CrossRefGoogle Scholar
  5. 5.
    Maher ER, Neumann HP, Richard S. von Hippel–Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19(6):617–23.CrossRefGoogle Scholar
  6. 6.
    Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. von Hippel–Lindau disease. Lancet. 2003;361(9374):2059–67.CrossRefGoogle Scholar
  7. 7.
    Eisenhofer G, Walther MM, Huynh T-T, Li S-T, Bornstein SR, Vortmeyer A, et al. Pheochromocytomas in von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab. 2001;86(5):1999–2008.CrossRefGoogle Scholar
  8. 8.
    Corcos O, Couvelard A, Giraud S, Vullierme M-P, O’Toole D, Rebours V, et al. Endocrine pancreatic tumors in von Hippel–Lindau disease. Pancreas. 2008;37(1):85–93.CrossRefGoogle Scholar
  9. 9.
    Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, et al. Pancreatic involvement in von Hippel–Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel–Lindau. Gastroenterology. 2000;119(4):1087–95.CrossRefGoogle Scholar
  10. 10.
    Richard S, Gardie B, Couvé S, Gad S. Von Hippel–Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 2013;23(1):26–37.CrossRefGoogle Scholar
  11. 11.
    Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel–Lindau disease. JAMA. 1997;277(18):1461–6.CrossRefGoogle Scholar
  12. 12.
    Choo D, Shotland L, Mastroianni M, Glenn G, van WC, Linehan WM, et al. Endolymphatic sac tumors in von Hippel–Lindau disease. J Neurosurg. 2004;100(3):480–7.CrossRefGoogle Scholar
  13. 13.
    Frantzen C, Kruizinga RC, Van Asselt SJ, Zonnenberg BA, Lenders JWM, De Herder WW, et al. Pregnancy-related hemangioblastoma progression and complications in von Hippel–Lindau disease. Neurology. 2012;79(8):793–6.CrossRefGoogle Scholar
  14. 14.
    Hayden MG, Gephart R, Kalanithi P, Chou D. Von Hippel–Lindau disease in pregnancy: a brief review. J Clin Neurosci. 2009;16(5):611–3.CrossRefGoogle Scholar
  15. 15.
    Binderup MLM, Budtz-Jørgensen E, Bisgaard ML. New von Hippel–Lindau manifestations develop at the same or decreased rates in pregnancy. Neurology. 2015;85(17):1500–3.CrossRefGoogle Scholar
  16. 16.
    Kolomeyevskaya N, Blazo M, Van den Veyver I, Strehlow S, Aagaard-Tillery K. Pheochromocytoma and Von Hippel–Lindau in pregnancy. Am J Perinatol. 2010;27(3):257–63.CrossRefGoogle Scholar
  17. 17.
    Chi JH, Manley GT, Chou D. Pregnancy-related vertebral hemangioma. Case report, review of the literature, and management algorithm. Neurosurg Focus. 2005;19(3):E7.CrossRefGoogle Scholar
  18. 18.
    Hallsworth D, Thompson J, Wilkinson D, Kerr RSC, Russell R. Intracranial pressure monitoring and caesarean section in a patient with von Hippel–Lindau disease and symptomatic cerebellar haemangioblastomas. Int J Obstet Anesth. 2015;24(1):73–7.CrossRefGoogle Scholar
  19. 19.
    Monge E, Botella M, Rueda ML, Navia J. Anesthesia for cesarean section in a patient with von Hippel–Lindau disease. Rev Esp Anestesiol Reanim. 2002;49(7):377–80.PubMedGoogle Scholar
  20. 20.
    Adekola H, Soto E, Lam J, Bronshtein E, Chaiworapongsa T, Sorokin Y. von Hippel–Lindau disease and pregnancy. Obstet Gynecol Surv. 2013;68(9):655–62.CrossRefGoogle Scholar
  21. 21.
    McCarthy T, Leighton R, Mushambi M. Spinal anaesthesia for caesarean section for a woman with von Hippel Lindau disease. Int J Obstet Anesth. 2010;19(4):461–2.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations